Table 2 Comparative analysis of the changes in severity, frequency, and duration of migraine attacks before and after intervention in both groups
Migraine features | Baseline | 1 month | 3 months | ||||||
|---|---|---|---|---|---|---|---|---|---|
Intervention group n = 28 | Control group n = 30 | Test valuea p value | Intervention group n = 28 | Control group n = 30 | Test valuea p value | Intervention group n = 28 | Control group n = 30 | Test valuea p value | |
Severity of migraine attacksb | 7.43 ± 1.23 | 7.40 ± 1.19 | 0.09 0.93 | 5.71 ± 1.05 | 6.03 ± 1.27 | 1.04 0.30 | 4.07 ± 1.09 | 6.23 ± 1.57 | 6.14 < 0.001* |
Frequency of migraine days/m | |||||||||
0–3 days/m | 0 (0%) | 0 (0%) | 0.42# 1.00 | 0 (0%) | 0 (0%) | 0.53# 0.86 | 1 (3.6%) | 0 (0%) | 20.87# < 0.001* |
4–7 days /m | 1 (3.6%) | 2 (6.7%) | 4 (14.3%) | 5 (16.7%) | 18 (64.3%) | 4 (13.3%) | |||
8–14 days/m | 11(39.3%) | 12 (40%) | 20 (71.4%) | 19 (63.3%) | 9 (32.1%) | 19 (63.4%) | |||
≥ 15 days/m | 16 (57.1%) | 16 (53.3%) | 4 (14.3%) | 6 (20%) | 0 (0%) | 7 (23.3%) | |||
Average duration of migraine attack | |||||||||
< 12 h | 2 (7.1%) | 1 (3.3%) | 4.04# 0.13 | 3 (10.7%) | 1 (3.3%) | 1.97 0.37 | 8 (28.6%) | 1 (3.3%) | 14.13# < 0.001* |
12–24 h | 2 (7.1%) | 8 (26.7%) | 15 (53.6%) | 14 (46.7%) | 19 (67.8%) | 18 (60%) | |||
> 24 h | 24 (85.8%) | 21 (70%) | 10 (35.7%) | 15 (50%) | 1 (3.6%) | 11 (36.7%) | |||